アクチビン受容体タイプ1の世界市場（～2026年）

• 英文タイトル：Global Activin Receptor Type 1 Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY02083 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はアクチビン受容体タイプ1のグローバル市場について調査・分析したレポートです。種類別（LJPC-6417、TP-0184、ジピリダモール、その他）市場規模、用途別（アルポート症候群、慢性腎臓病、腎線維化、肥満、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別アクチビン受容体タイプ1の競争状況、市場シェア ・世界のアクチビン受容体タイプ1市場：種類別市場規模 2015年-2020年（LJPC-6417、TP-0184、ジピリダモール、その他） ・世界のアクチビン受容体タイプ1市場：種類別市場規模予測 2021年-2026年（LJPC-6417、TP-0184、ジピリダモール、その他） ・世界のアクチビン受容体タイプ1市場：用途別市場規模 2015年-2020年（アルポート症候群、慢性腎臓病、腎線維化、肥満、その他） ・世界のアクチビン受容体タイプ1市場：用途別市場規模予測 2021年-2026年（アルポート症候群、慢性腎臓病、腎線維化、肥満、その他） ・北米のアクチビン受容体タイプ1市場分析：米国、カナダ ・ヨーロッパのアクチビン受容体タイプ1市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのアクチビン受容体タイプ1市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のアクチビン受容体タイプ1市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのアクチビン受容体タイプ1市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Blueprint Medicines Corp、Daiichi Sankyo Company Ltd、La Jolla Pharmaceutical Company、Oncodesign SA、Tolero Pharmaceuticals Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Activin Receptor Type 1 Market
The global Activin Receptor Type 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Activin Receptor Type 1 Scope and Market Size
Activin Receptor Type 1 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Activin Receptor Type 1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Activin Receptor Type 1 market is segmented into
LJPC-6417
TP-0184
Dipyridamole
Others

Segment by Application, the Activin Receptor Type 1 market is segmented into
Alport Syndrome
Chronic Kidney Disease
Kidney Fibrosis
Obesity
Others

Regional and Country-level Analysis
The Activin Receptor Type 1 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Activin Receptor Type 1 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Activin Receptor Type 1 Market Share Analysis
Activin Receptor Type 1 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Activin Receptor Type 1 business, the date to enter into the Activin Receptor Type 1 market, Activin Receptor Type 1 product introduction, recent developments, etc.

The major vendors covered:
Blueprint Medicines Corp
Daiichi Sankyo Company Ltd
La Jolla Pharmaceutical Company
Oncodesign SA
Tolero Pharmaceuticals Inc
…

レポート目次

---

1 Study Coverage
1.1 Activin Receptor Type 1 Product Introduction
1.2 Market Segments
1.3 Key Activin Receptor Type 1 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Activin Receptor Type 1 Market Size Growth Rate by Type
1.4.2 LJPC-6417
1.4.3 TP-0184
1.4.4 Dipyridamole
1.4.5 Others
1.5 Market by Application
1.5.1 Global Activin Receptor Type 1 Market Size Growth Rate by Application
1.5.2 Alport Syndrome
1.5.3 Chronic Kidney Disease
1.5.4 Kidney Fibrosis
1.5.5 Obesity
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Activin Receptor Type 1 Market Size, Estimates and Forecasts
2.1.1 Global Activin Receptor Type 1 Revenue 2015-2026
2.1.2 Global Activin Receptor Type 1 Sales 2015-2026
2.2 Global Activin Receptor Type 1, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Activin Receptor Type 1 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Activin Receptor Type 1 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Activin Receptor Type 1 Competitor Landscape by Players
3.1 Activin Receptor Type 1 Sales by Manufacturers
3.1.1 Activin Receptor Type 1 Sales by Manufacturers (2015-2020)
3.1.2 Activin Receptor Type 1 Sales Market Share by Manufacturers (2015-2020)
3.2 Activin Receptor Type 1 Revenue by Manufacturers
3.2.1 Activin Receptor Type 1 Revenue by Manufacturers (2015-2020)
3.2.2 Activin Receptor Type 1 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Activin Receptor Type 1 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Activin Receptor Type 1 Revenue in 2019
3.2.5 Global Activin Receptor Type 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Activin Receptor Type 1 Price by Manufacturers
3.4 Activin Receptor Type 1 Manufacturing Base Distribution, Product Types
3.4.1 Activin Receptor Type 1 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Activin Receptor Type 1 Product Type
3.4.3 Date of International Manufacturers Enter into Activin Receptor Type 1 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Activin Receptor Type 1 Market Size by Type (2015-2020)
4.1.1 Global Activin Receptor Type 1 Sales by Type (2015-2020)
4.1.2 Global Activin Receptor Type 1 Revenue by Type (2015-2020)
4.1.3 Activin Receptor Type 1 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Activin Receptor Type 1 Market Size Forecast by Type (2021-2026)
4.2.1 Global Activin Receptor Type 1 Sales Forecast by Type (2021-2026)
4.2.2 Global Activin Receptor Type 1 Revenue Forecast by Type (2021-2026)
4.2.3 Activin Receptor Type 1 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Activin Receptor Type 1 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Activin Receptor Type 1 Market Size by Application (2015-2020)
5.1.1 Global Activin Receptor Type 1 Sales by Application (2015-2020)
5.1.2 Global Activin Receptor Type 1 Revenue by Application (2015-2020)
5.1.3 Activin Receptor Type 1 Price by Application (2015-2020)
5.2 Activin Receptor Type 1 Market Size Forecast by Application (2021-2026)
5.2.1 Global Activin Receptor Type 1 Sales Forecast by Application (2021-2026)
5.2.2 Global Activin Receptor Type 1 Revenue Forecast by Application (2021-2026)
5.2.3 Global Activin Receptor Type 1 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Activin Receptor Type 1 by Country
6.1.1 North America Activin Receptor Type 1 Sales by Country
6.1.2 North America Activin Receptor Type 1 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Activin Receptor Type 1 Market Facts & Figures by Type
6.3 North America Activin Receptor Type 1 Market Facts & Figures by Application

7 Europe
7.1 Europe Activin Receptor Type 1 by Country
7.1.1 Europe Activin Receptor Type 1 Sales by Country
7.1.2 Europe Activin Receptor Type 1 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Activin Receptor Type 1 Market Facts & Figures by Type
7.3 Europe Activin Receptor Type 1 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Activin Receptor Type 1 by Region
8.1.1 Asia Pacific Activin Receptor Type 1 Sales by Region
8.1.2 Asia Pacific Activin Receptor Type 1 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Activin Receptor Type 1 Market Facts & Figures by Type
8.3 Asia Pacific Activin Receptor Type 1 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Activin Receptor Type 1 by Country
9.1.1 Latin America Activin Receptor Type 1 Sales by Country
9.1.2 Latin America Activin Receptor Type 1 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Activin Receptor Type 1 Market Facts & Figures by Type
9.3 Central & South America Activin Receptor Type 1 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Activin Receptor Type 1 by Country
10.1.1 Middle East and Africa Activin Receptor Type 1 Sales by Country
10.1.2 Middle East and Africa Activin Receptor Type 1 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Activin Receptor Type 1 Market Facts & Figures by Type
10.3 Middle East and Africa Activin Receptor Type 1 Market Facts & Figures by Application

11 Company Profiles
11.1 Blueprint Medicines Corp
11.1.1 Blueprint Medicines Corp Corporation Information
11.1.2 Blueprint Medicines Corp Description and Business Overview
11.1.3 Blueprint Medicines Corp Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Blueprint Medicines Corp Activin Receptor Type 1 Products Offered
11.1.5 Blueprint Medicines Corp Related Developments
11.2 Daiichi Sankyo Company Ltd
11.2.1 Daiichi Sankyo Company Ltd Corporation Information
11.2.2 Daiichi Sankyo Company Ltd Description and Business Overview
11.2.3 Daiichi Sankyo Company Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Products Offered
11.2.5 Daiichi Sankyo Company Ltd Related Developments
11.3 La Jolla Pharmaceutical Company
11.3.1 La Jolla Pharmaceutical Company Corporation Information
11.3.2 La Jolla Pharmaceutical Company Description and Business Overview
11.3.3 La Jolla Pharmaceutical Company Sales, Revenue and Gross Margin (2015-2020)
11.3.4 La Jolla Pharmaceutical Company Activin Receptor Type 1 Products Offered
11.3.5 La Jolla Pharmaceutical Company Related Developments
11.4 Oncodesign SA
11.4.1 Oncodesign SA Corporation Information
11.4.2 Oncodesign SA Description and Business Overview
11.4.3 Oncodesign SA Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Oncodesign SA Activin Receptor Type 1 Products Offered
11.4.5 Oncodesign SA Related Developments
11.5 Tolero Pharmaceuticals Inc
11.5.1 Tolero Pharmaceuticals Inc Corporation Information
11.5.2 Tolero Pharmaceuticals Inc Description and Business Overview
11.5.3 Tolero Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Products Offered
11.5.5 Tolero Pharmaceuticals Inc Related Developments
11.1 Blueprint Medicines Corp
11.1.1 Blueprint Medicines Corp Corporation Information
11.1.2 Blueprint Medicines Corp Description and Business Overview
11.1.3 Blueprint Medicines Corp Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Blueprint Medicines Corp Activin Receptor Type 1 Products Offered
11.1.5 Blueprint Medicines Corp Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Activin Receptor Type 1 Market Estimates and Projections by Region
12.1.1 Global Activin Receptor Type 1 Sales Forecast by Regions 2021-2026
12.1.2 Global Activin Receptor Type 1 Revenue Forecast by Regions 2021-2026
12.2 North America Activin Receptor Type 1 Market Size Forecast (2021-2026)
12.2.1 North America: Activin Receptor Type 1 Sales Forecast (2021-2026)
12.2.2 North America: Activin Receptor Type 1 Revenue Forecast (2021-2026)
12.2.3 North America: Activin Receptor Type 1 Market Size Forecast by Country (2021-2026)
12.3 Europe Activin Receptor Type 1 Market Size Forecast (2021-2026)
12.3.1 Europe: Activin Receptor Type 1 Sales Forecast (2021-2026)
12.3.2 Europe: Activin Receptor Type 1 Revenue Forecast (2021-2026)
12.3.3 Europe: Activin Receptor Type 1 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Activin Receptor Type 1 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Activin Receptor Type 1 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Activin Receptor Type 1 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Activin Receptor Type 1 Market Size Forecast by Region (2021-2026)
12.5 Latin America Activin Receptor Type 1 Market Size Forecast (2021-2026)
12.5.1 Latin America: Activin Receptor Type 1 Sales Forecast (2021-2026)
12.5.2 Latin America: Activin Receptor Type 1 Revenue Forecast (2021-2026)
12.5.3 Latin America: Activin Receptor Type 1 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Activin Receptor Type 1 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Activin Receptor Type 1 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Activin Receptor Type 1 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Activin Receptor Type 1 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Activin Receptor Type 1 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Activin Receptor Type 1 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Activin Receptor Type 1 Market Segments
Table 2. Ranking of Global Top Activin Receptor Type 1 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Activin Receptor Type 1 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of LJPC-6417
Table 5. Major Manufacturers of TP-0184
Table 6. Major Manufacturers of Dipyridamole
Table 7. Major Manufacturers of Others
Table 8. Global Activin Receptor Type 1 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Activin Receptor Type 1 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Activin Receptor Type 1 Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Activin Receptor Type 1 Sales Market Share by Regions (2015-2020)
Table 12. Global Activin Receptor Type 1 Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Activin Receptor Type 1 Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Activin Receptor Type 1 Sales Share by Manufacturers (2015-2020)
Table 15. Global Activin Receptor Type 1 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Activin Receptor Type 1 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Activin Receptor Type 1 as of 2019)
Table 17. Activin Receptor Type 1 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Activin Receptor Type 1 Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Activin Receptor Type 1 Price (2015-2020) (USD/Pcs)
Table 20. Activin Receptor Type 1 Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Activin Receptor Type 1 Product Type
Table 22. Date of International Manufacturers Enter into Activin Receptor Type 1 Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Activin Receptor Type 1 Sales by Type (2015-2020) (K Pcs)
Table 25. Global Activin Receptor Type 1 Sales Share by Type (2015-2020)
Table 26. Global Activin Receptor Type 1 Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Activin Receptor Type 1 Revenue Share by Type (2015-2020)
Table 28. Activin Receptor Type 1 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Activin Receptor Type 1 Sales by Application (2015-2020) (K Pcs)
Table 30. Global Activin Receptor Type 1 Sales Share by Application (2015-2020)
Table 31. North America Activin Receptor Type 1 Sales by Country (2015-2020) (K Pcs)
Table 32. North America Activin Receptor Type 1 Sales Market Share by Country (2015-2020)
Table 33. North America Activin Receptor Type 1 Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Activin Receptor Type 1 Revenue Market Share by Country (2015-2020)
Table 35. North America Activin Receptor Type 1 Sales by Type (2015-2020) (K Pcs)
Table 36. North America Activin Receptor Type 1 Sales Market Share by Type (2015-2020)
Table 37. North America Activin Receptor Type 1 Sales by Application (2015-2020) (K Pcs)
Table 38. North America Activin Receptor Type 1 Sales Market Share by Application (2015-2020)
Table 39. Europe Activin Receptor Type 1 Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Activin Receptor Type 1 Sales Market Share by Country (2015-2020)
Table 41. Europe Activin Receptor Type 1 Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Activin Receptor Type 1 Revenue Market Share by Country (2015-2020)
Table 43. Europe Activin Receptor Type 1 Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Activin Receptor Type 1 Sales Market Share by Type (2015-2020)
Table 45. Europe Activin Receptor Type 1 Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Activin Receptor Type 1 Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Activin Receptor Type 1 Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Activin Receptor Type 1 Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Activin Receptor Type 1 Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Activin Receptor Type 1 Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Activin Receptor Type 1 Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Activin Receptor Type 1 Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Activin Receptor Type 1 Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Activin Receptor Type 1 Sales Market Share by Application (2015-2020)
Table 55. Latin America Activin Receptor Type 1 Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Activin Receptor Type 1 Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Activin Receptor Type 1 Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Activin Receptor Type 1 Revenue Market Share by Country (2015-2020)
Table 59. Latin America Activin Receptor Type 1 Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Activin Receptor Type 1 Sales Market Share by Type (2015-2020)
Table 61. Latin America Activin Receptor Type 1 Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Activin Receptor Type 1 Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Activin Receptor Type 1 Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Activin Receptor Type 1 Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Activin Receptor Type 1 Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Activin Receptor Type 1 Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Activin Receptor Type 1 Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Activin Receptor Type 1 Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Activin Receptor Type 1 Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Activin Receptor Type 1 Sales Market Share by Application (2015-2020)
Table 71. Blueprint Medicines Corp Corporation Information
Table 72. Blueprint Medicines Corp Description and Major Businesses
Table 73. Blueprint Medicines Corp Activin Receptor Type 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Blueprint Medicines Corp Product
Table 75. Blueprint Medicines Corp Recent Development
Table 76. Daiichi Sankyo Company Ltd Corporation Information
Table 77. Daiichi Sankyo Company Ltd Description and Major Businesses
Table 78. Daiichi Sankyo Company Ltd Activin Receptor Type 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Daiichi Sankyo Company Ltd Product
Table 80. Daiichi Sankyo Company Ltd Recent Development
Table 81. La Jolla Pharmaceutical Company Corporation Information
Table 82. La Jolla Pharmaceutical Company Description and Major Businesses
Table 83. La Jolla Pharmaceutical Company Activin Receptor Type 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. La Jolla Pharmaceutical Company Product
Table 85. La Jolla Pharmaceutical Company Recent Development
Table 86. Oncodesign SA Corporation Information
Table 87. Oncodesign SA Description and Major Businesses
Table 88. Oncodesign SA Activin Receptor Type 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Oncodesign SA Product
Table 90. Oncodesign SA Recent Development
Table 91. Tolero Pharmaceuticals Inc Corporation Information
Table 92. Tolero Pharmaceuticals Inc Description and Major Businesses
Table 93. Tolero Pharmaceuticals Inc Activin Receptor Type 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Tolero Pharmaceuticals Inc Product
Table 95. Tolero Pharmaceuticals Inc Recent Development
Table 96. Global Activin Receptor Type 1 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 97. Global Activin Receptor Type 1 Sales Market Share Forecast by Regions (2021-2026)
Table 98. Global Activin Receptor Type 1 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 99. Global Activin Receptor Type 1 Revenue Market Share Forecast by Regions (2021-2026)
Table 100. North America: Activin Receptor Type 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 101. North America: Activin Receptor Type 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Europe: Activin Receptor Type 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Europe: Activin Receptor Type 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Asia Pacific: Activin Receptor Type 1 Sales Forecast by Region (2021-2026) (K Pcs)
Table 105. Asia Pacific: Activin Receptor Type 1 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 106. Latin America: Activin Receptor Type 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. Latin America: Activin Receptor Type 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Middle East and Africa: Activin Receptor Type 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Middle East and Africa: Activin Receptor Type 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 111. Key Challenges
Table 112. Market Risks
Table 113. Main Points Interviewed from Key Activin Receptor Type 1 Players
Table 114. Activin Receptor Type 1 Customers List
Table 115. Activin Receptor Type 1 Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Activin Receptor Type 1 Product Picture
Figure 2. Global Activin Receptor Type 1 Sales Market Share by Type in 2020 & 2026
Figure 3. LJPC-6417 Product Picture
Figure 4. TP-0184 Product Picture
Figure 5. Dipyridamole Product Picture
Figure 6. Others Product Picture
Figure 7. Global Activin Receptor Type 1 Sales Market Share by Application in 2020 & 2026
Figure 8. Alport Syndrome
Figure 9. Chronic Kidney Disease
Figure 10. Kidney Fibrosis
Figure 11. Obesity
Figure 12. Others
Figure 13. Activin Receptor Type 1 Report Years Considered
Figure 14. Global Activin Receptor Type 1 Market Size 2015-2026 (US$ Million)
Figure 15. Global Activin Receptor Type 1 Sales 2015-2026 (K Pcs)
Figure 16. Global Activin Receptor Type 1 Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Activin Receptor Type 1 Sales Market Share by Region (2015-2020)
Figure 18. Global Activin Receptor Type 1 Sales Market Share by Region in 2019
Figure 19. Global Activin Receptor Type 1 Revenue Market Share by Region (2015-2020)
Figure 20. Global Activin Receptor Type 1 Revenue Market Share by Region in 2019
Figure 21. Global Activin Receptor Type 1 Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Activin Receptor Type 1 Revenue in 2019
Figure 23. Activin Receptor Type 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Activin Receptor Type 1 Sales Market Share by Type (2015-2020)
Figure 25. Global Activin Receptor Type 1 Sales Market Share by Type in 2019
Figure 26. Global Activin Receptor Type 1 Revenue Market Share by Type (2015-2020)
Figure 27. Global Activin Receptor Type 1 Revenue Market Share by Type in 2019
Figure 28. Global Activin Receptor Type 1 Market Share by Price Range (2015-2020)
Figure 29. Global Activin Receptor Type 1 Sales Market Share by Application (2015-2020)
Figure 30. Global Activin Receptor Type 1 Sales Market Share by Application in 2019
Figure 31. Global Activin Receptor Type 1 Revenue Market Share by Application (2015-2020)
Figure 32. Global Activin Receptor Type 1 Revenue Market Share by Application in 2019
Figure 33. North America Activin Receptor Type 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Activin Receptor Type 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Activin Receptor Type 1 Sales Market Share by Country in 2019
Figure 36. North America Activin Receptor Type 1 Revenue Market Share by Country in 2019
Figure 37. U.S. Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Activin Receptor Type 1 Market Share by Type in 2019
Figure 42. North America Activin Receptor Type 1 Market Share by Application in 2019
Figure 43. Europe Activin Receptor Type 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Activin Receptor Type 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Activin Receptor Type 1 Sales Market Share by Country in 2019
Figure 46. Europe Activin Receptor Type 1 Revenue Market Share by Country in 2019
Figure 47. Germany Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Activin Receptor Type 1 Market Share by Type in 2019
Figure 58. Europe Activin Receptor Type 1 Market Share by Application in 2019
Figure 59. Asia Pacific Activin Receptor Type 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Activin Receptor Type 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Activin Receptor Type 1 Sales Market Share by Region in 2019
Figure 62. Asia Pacific Activin Receptor Type 1 Revenue Market Share by Region in 2019
Figure 63. China Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Activin Receptor Type 1 Market Share by Type in 2019
Figure 86. Asia Pacific Activin Receptor Type 1 Market Share by Application in 2019
Figure 87. Latin America Activin Receptor Type 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Activin Receptor Type 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Activin Receptor Type 1 Sales Market Share by Country in 2019
Figure 90. Latin America Activin Receptor Type 1 Revenue Market Share by Country in 2019
Figure 91. Mexico Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Activin Receptor Type 1 Market Share by Type in 2019
Figure 98. Latin America Activin Receptor Type 1 Market Share by Application in 2019
Figure 99. Middle East and Africa Activin Receptor Type 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Activin Receptor Type 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Activin Receptor Type 1 Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Activin Receptor Type 1 Revenue Market Share by Country in 2019
Figure 103. Turkey Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Activin Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Activin Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Activin Receptor Type 1 Market Share by Type in 2019
Figure 110. Middle East and Africa Activin Receptor Type 1 Market Share by Application in 2019
Figure 111. North America Activin Receptor Type 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Activin Receptor Type 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Activin Receptor Type 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Activin Receptor Type 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Activin Receptor Type 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Activin Receptor Type 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Activin Receptor Type 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Activin Receptor Type 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Activin Receptor Type 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Activin Receptor Type 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed

---